These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 24911578)
1. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants. Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578 [TBL] [Abstract][Full Text] [Related]
2. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression. Hsiao CC Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529 [TBL] [Abstract][Full Text] [Related]
3. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506 [TBL] [Abstract][Full Text] [Related]
4. Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression. Hough CM; Lindqvist D; Epel ES; Denis MS; Reus VI; Bersani FS; Rosser R; Mahan L; Burke HM; Wolkowitz OM; Mellon SH Psychoneuroendocrinology; 2017 Mar; 77():122-130. PubMed ID: 28038403 [TBL] [Abstract][Full Text] [Related]
5. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city]. Mouchabac S; Ferreri M; Cabanac F; Bitton M Encephale; 2003; 29(5):438-44. PubMed ID: 14615693 [TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292 [TBL] [Abstract][Full Text] [Related]
8. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients. Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658 [TBL] [Abstract][Full Text] [Related]
9. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment. Paslakis G; Luppa P; Gilles M; Kopf D; Hamann-Weber B; Lederbogen F; Deuschle M J Psychiatr Res; 2010 Jun; 44(8):556-60. PubMed ID: 20022345 [TBL] [Abstract][Full Text] [Related]
10. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961 [TBL] [Abstract][Full Text] [Related]
11. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344 [TBL] [Abstract][Full Text] [Related]
12. Positive correlation between anxiety severity and plasma levels of dehydroepiandrosterone sulfate in medication-free patients experiencing a major episode of depression. Hsiao CC Psychiatry Clin Neurosci; 2006 Dec; 60(6):746-50. PubMed ID: 17109709 [TBL] [Abstract][Full Text] [Related]
13. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report. Braund TA; Palmer DM; Williams LM; Harris AW Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405 [TBL] [Abstract][Full Text] [Related]
14. Plasma galanin is a biomarker for severity of major depressive disorder. Wang YJ; Yang YT; Li H; Liu PZ; Wang CY; Xu ZQ Int J Psychiatry Med; 2014; 48(2):109-19. PubMed ID: 25377152 [TBL] [Abstract][Full Text] [Related]
15. Residual anxiety symptoms in depressed primary care patients. McIntyre RS; Konarski JZ; Soczynska JK; Kennedy SH J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691 [TBL] [Abstract][Full Text] [Related]
17. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Akiskal HS; Benazzi F; Perugi G; Rihmer Z J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694 [TBL] [Abstract][Full Text] [Related]
18. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Suri R; Altshuler L; Hellemann G; Burt VK; Aquino A; Mintz J Am J Psychiatry; 2007 Aug; 164(8):1206-13. PubMed ID: 17671283 [TBL] [Abstract][Full Text] [Related]
19. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. Huang TL; Lee CT; Liu YL J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940 [TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ; Ferrando SJ Am J Psychiatry; 2006 Jan; 163(1):59-66. PubMed ID: 16390890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]